Hakan Kılıçaslan

Hakan Kılıçaslan

Auto-generated profile, based on publicly available information

Hakan Kılıçaslan

Department of Neurology, University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2025 in The European Research Journal
Verified
Journal Article
Open access
YFYelda Ali FIRAT
Yelda Ali FIRAT
MSMeral Seferoğlu
Meral Seferoğlu
HKHakan Kılıçaslan
Hakan Kılıçaslan
ASAli Özhan Sıvacı
Ali Özhan Sıvacı
MYMurat Kaan Yılmaz
Murat Kaan Yılmaz
YKYılmaz Kılıçaslan
Yılmaz Kılıçaslan
Objectives: Multiple sclerosis (MS) is a chronic central nervous system disorder that causes demyelination, inflammation, and axonal damage, leading to permanent disabilities in motor, sensory, visual, and balance functions. This study aimed to develop an artificial intelligence (AI)-based, non-invasive diagnostic approach for MS detection using handwriting analysis, leveraging deep learning methods to identify disease-specific handwriting patterns. Methods: A classification model was designed using a convolutional neural network (CNN) based on the VGG16 architecture with transfer learning. The dataset consisted of 426 handwriting samples, including 213 from MS patients and 213 from healthy individuals. Data augmentation and early stopping techniques were employed to improve model generalization capability. Results: The proposed model achieved a validation accuracy of 83.72% and a test accuracy of 85%, indicating its robustness in distinguishing MS patients from healthy subjects. The confusion matrix analysis demonstrated a sensitivity of 86% and a specificity of 84%, indicating moderate discriminatory performance. Conclusions: The findings suggest that the developed AI-based model offers an effective, non-invasive diagnostic tool for MS detection. This approach provides a promising foundation for future research on monitoring disease progression and developing clinically applicable AI-supported diagnostic systems.